Sangamo BioSciences | 营业利润





营业利润 更改 日
Alaunos Therapeutics USD -1.19M 432K 2025-09
Alnylam Pharmaceuticals USD -29.96M 13.76M 2025-09
Alterity Therapeutics Limited AUD -7.77M 2.99M 2023-06
Amgen USD 3.96B 464M 2025-12
Bayer EUR -543M 556M 2025-09
BioCryst Pharmaceuticals USD -2.54M 10.23M 2024-12
Biogen USD 659.6M 192.2M 2025-09
BioMarin Pharmaceutical USD -31.69M 308.58M 2025-09
Cipla INR 9.77B 6.21B 2025-12
Clal Biotechnology ILS -1.74M 7.46M 2022-12
Compugen USD -7.89M 540K 2025-09
CSL USD 666M 1.31B 2025-06
Gilead Sciences USD 2.96B 551M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Grifols EUR 411.56M 15.51M 2025-09
Ionis Pharmaceuticals USD -160.18M 300.02M 2025-09
J&J USD 5.59B 1.81B 2025-12
Karyopharm Therapeutics USD -31.28M 5M 2024-12
Merck USD 6.24B 318M 2025-12
Novartis USD 4.5B 363M 2025-09
Omeros USD -35.41M 23.75M 2024-09
Pfizer USD 4.65B 3.99B 2025-12
Roche Holding CHF 9.56B 3.8B 2025-12
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Sanofi EUR 1.7B 2.17B 2025-12
Sarepta Therapeutics USD -62.88M 178.46M 2025-09
Tectonic Therapeutic USD -21.89M 440K 2025-09
Ultragenyx Pharmaceutical USD -170.89M 22.68M 2025-09
Vertex Pharmaceuticals USD 1.24B 84.6M 2025-09


Sangamo BioSciences 营业利润 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.